GLP-1 Agonists Market Size, Share & Trends Analysis Report By Product (Branded GLP-1 Agonists, Dual / Triple, Biosimilars & Generic GLP-1 Agonists Agonists), By Indication (Type 2 Diabetes Mellitus, Obesity / Overweight Management, Cardiovascular & Metabolic Related Indications, Other Emerging Indications (e.g., NASH, Alzheimers-related)), By Route of Administration, By Distribution Channel, By Region and By Segments Forecasts, 2025-2034 GLP-1 Agonists Market Size is valued at USD 43.1 Bn in 2024 and is predicted to reach USD 260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034
Choline: A nutrient that supports liver function, helps metabolize fats, and assists in the transport of fats and cholesterol
Responsible entity: OSHEE POLSKA SP
First, Web of Science, PubMed, and Scopus databases were comprehensively searched for clinical studies assessing the effects of GLP-1-based therapies on anthropometric indices and body composition in the specified populations
The bilayer membrane structure of liposomes guarantees that both water-soluble compounds and fat-soluble compounds can be efficiently and simultaneously entrapped within it